The overall aim of the project is to further develop and validate a new comprehensive concentration-time-effect modeling paradigm, created during the last 3-year funding period of RRI 0742 for single agents and for high order combinations of agents, for anticancer chemotherapy and other pharmacological applications, with new emphases on the measurement of individual cell responses, cell response heterogeneity quantification, assays of molecular targets, and the use of molecularly-targeted agents. The final modeling paradigm which will result from this project is intended to bridge the gap between traditional pharmacometrics and the new era of molecular bioinformatics.
The Specific Aims i nclude: 1. The validity and utility of a new mathematical! . statistical modeling paradigm, derived to describe concentration-time-effect phenomena for single agents and 2-agent, 3-agent, 4-agent and 5-agent combinations, will be investigated in a well-characterized, simple in vitro antiproliferation assay, the total growth assay (TGA). Specific combinations of anticancer agents will include both classic clinically-used agents and novel molecularly-targeted signal transduction inhibitors. 2. A multiplex time lapse video system (mpTLV) with automated image analysis tracking of cells in the digital video record will be developed, to allow detailed analysis of cellular response to anticancer agents to be done rapidly. 3. Mathematical/statistical models of proliferative and cell death response to single anticancer agents and combinations of agents, that include individual cell responses of growth delay, growth slow-down, growth arrest, apoptosis, and other forms of cell death, will be derived to provide a more detailed knowledge of cellular response. 4. D-optimal statistical design methodology for the Hill concentration-effect model developed under RR1 0742 for single agent concentration-effect studies, will be further developed for applications to the complex studies in Specific Aims #1 and #3. 5. An Internet Web site will be created to give the scientific public assess to: the rich data sets generated; the data analysis and modeling tools developed; results; and a discussion room for the general topic of concentration-time-effect and synergy modeling.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Research Project (R01)
Project #
2R01RR010742-09
Application #
6328169
Study Section
Special Emphasis Panel (ZRG1-ET-1 (03))
Program Officer
Chang, Michael
Project Start
1989-04-01
Project End
2004-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
9
Fiscal Year
2001
Total Cost
$382,199
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Brun, Yseult Francoise; Greco, William R (2010) Characterization of a three-drug nonlinear mixture response model. Front Biosci (Schol Ed) 2:454-67
Khinkis, Leonid A; Krzyzanski, Wojciech; Jusko, William J et al. (2009) D-optimal designs for parameter estimation for indirect pharmacodynamic response models. J Pharmacokinet Pharmacodyn 36:523-39
Brun, Yseult F; Varma, Ram; Hector, Suzanne M et al. (2008) Simultaneous modeling of concentration-effect and time-course patterns in gene expression data from microarrays. Cancer Genomics Proteomics 5:43-53
Brun, Yseult F; Dennis, Carly G; Greco, William R et al. (2007) Modeling the combination of amphotericin B, micafungin, and nikkomycin Z against Aspergillus fumigatus in vitro using a novel response surface paradigm. Antimicrob Agents Chemother 51:1804-12
Varma, Ram; Hector, Suzanne; Greco, William R et al. (2007) Platinum drug effects on the expression of genes in the polyamine pathway: time-course and concentration-effect analysis based on Affymetrix gene expression profiling of A2780 ovarian carcinoma cells. Cancer Chemother Pharmacol 59:711-23
Kau, Yi-Chuan; Hung, Yu-Chun; Zizza, Anthony M et al. (2006) Efficacy of lidocaine or bupivacaine combined with ephedrine in rat sciatic nerve block. Reg Anesth Pain Med 31:14-8
Varma, Rama R; Hector, Suzanne M; Clark, Kimberly et al. (2005) Gene expression profiling of a clonal isolate of oxaliplatin-resistant ovarian carcinoma cell line A2780/C10. Oncol Rep 14:925-32
Faessel, Helene M; Slocum, Harry K; Rustum, Youcef M et al. (2003) Thymidine and hypoxanthine protection patterns of the folic acid-enhanced synergies for combinations of trimetrexate plus a polyglutamylatable inhibitor of purine or thymidylate synthesis against human ileocecal HCT-8 cells. Int J Oncol 23:401-9
White, Donald B; Slocum, Harry K; Brun, Yseult et al. (2003) A new nonlinear mixture response surface paradigm for the study of synergism: a three drug example. Curr Drug Metab 4:399-409
Slocum, H K; Parsons, J C; Winslow, E O et al. (2000) Time-lapse video reveals immediate heterogeneity and heritable damage among human ileocecal carcinoma HCT-8 cells treated with raltitrexed (ZD1694). Cytometry 41:252-60

Showing the most recent 10 out of 18 publications